WHO ICTRP trial
Single arm, open, prospective study low dose of Apatinib in the treatment of…
ChiCTR1800015764 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800015764 |
|---|---|
| Public title | Single arm, open, prospective study low dose of Apatinib in the treatment of primary and recurrent high grade gliomas |
| Scientific title | Single arm, open, prospective study low dose of Apatinib in the treatment of primary and recurrent high grade gliomas |
| Primary sponsor | Gansu Province Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Post-market |
| Countries | China |
| Conditions | primary and recurrent high grade gliomas |
| Interventions | Case series:apatinib + Temozolomide + radiotherapy |
| Registration date | Apr 19, 2018 |
| Target size | Case series:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: